Correction to: Role of Bruton's tyrosine kinase in B cells and malignancies

Simar Pal Singh^{1

2

3}, Floris Dammeijer^{1

3

4}, Rudi W Hendriks⁵

Affiliations

¹ Department of Pulmonary Medicine, Room Ee2251a, Erasmus MC Rotterdam, PO Box 2040, NL 3000, CA, Rotterdam, The Netherlands.
² Department of Immunology, Rotterdam, The Netherlands.
³ Post graduate school Molecular Medicine, Rotterdam, The Netherlands.
⁴ Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
⁵ Department of Pulmonary Medicine, Room Ee2251a, Erasmus MC Rotterdam, PO Box 2040, NL 3000, CA, Rotterdam, The Netherlands. r.hendriks@erasmusmc.nl.

Published Erratum

Simar Pal Singh et al. Mol Cancer. 2019.

. 2019 Apr 3;18(1):79.

doi: 10.1186/s12943-019-1009-z.

Simar Pal Singh^{1

2

3}, Floris Dammeijer^{1

3

4}, Rudi W Hendriks⁵

¹ Department of Pulmonary Medicine, Room Ee2251a, Erasmus MC Rotterdam, PO Box 2040, NL 3000, CA, Rotterdam, The Netherlands.
² Department of Immunology, Rotterdam, The Netherlands.
³ Post graduate school Molecular Medicine, Rotterdam, The Netherlands.
⁴ Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, The Netherlands.
⁵ Department of Pulmonary Medicine, Room Ee2251a, Erasmus MC Rotterdam, PO Box 2040, NL 3000, CA, Rotterdam, The Netherlands. r.hendriks@erasmusmc.nl.

Abstract

Following publication of the original article [1], the authors reported an error in Table 1.

Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S, Dammeijer F, Hendriks RW. Pal Singh S, et al. Mol Cancer. 2018 Feb 19;17(1):57. doi: 10.1186/s12943-018-0779-z. Mol Cancer. 2018. PMID: 29455639 Free PMC article. Review.

1. Singh PS, Dammeijer F, Hendriks RW. Role of Bruton’s tyrosine kinase in B cellsand malignancies. Mol Cancer. 2018;17:57. doi: 10.1186/s12943-018-0779-z. - DOI - PMC - PubMed